Heron Therapeutics Inc (NASDAQ:HRTX) has found Phase 2 success with its lead product candidates for the prevention of post-operative pain, HTX-011 and HTX-011B. …
Heron Therapeutics Inc (NASDAQ:HRTX), has entered into an agreement with Tang Capital Partners, LP whereby Tang Capital will lend the Company up to …
Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical …
Heron Therapeutics Inc (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs, …
In a research report issued Thuesday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Heron Therapeutics Inc (NASDAQ:HRTX), with a …
While Illumina, Inc. (NASDAQ:ILMN) disappointed investors by lowering revenue outlook, Heron Therapeutics Inc (NASDAQ:HRTX) started the week off strong with good news from …
Heron Therapeutics Inc (NASDAQ:HRTX) announced that the U.S.
Cowen’s healthcare analyst Boris Peaker weighed in today on biotech firm Heron Therapeutics Inc (NASDAQ:HRTX), following the company’s fourth-quarter financial results and update on its clinical …
Heron Therapeutics Inc (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicine that address major unmet medical needs, …
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks 144 biotech and pharmaceutical companies – fell nearly 4% this week amid a renewed selloff in …
